Alphabet, Novartis and Johnson & Johnson have contributed to a series C round for Cala Health, which is preparing to release its wearable hand-tremor treatment device.
US-based wearable neuromodulation device manufacturer Cala Health completed a $50m series C round backed by internet and technology group Alphabet and pharmaceutical firms Novartis and Johnson & Johnson yesterday.
DRX Capital, a joint investment vehicle formed by Novartis and mobile chipset manufacturer Qualcomm, also took part in the round, as did LifeSci Venture Partners, part of investment firm and consultancy LifeSci Partners.
Baird Capital, TriVentures, Lux Capital, Lightstone Ventures and Action Potential Venture Capital filled out the round along with…
